Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
94.64
+4.68 (5.20%)
At close: May 12, 2025, 4:00 PM
94.64
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Glaukos Market Cap
Glaukos has a market cap or net worth of $5.41 billion as of May 12, 2025. Its market cap has increased by 8.25% in one year.
Market Cap
5.41B
Enterprise Value
5.19B
1-Year Change
8.25%
Ranking
Category
Stock Price
$94.64
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $5.41B, an increase of 440.73%. That is a compound annual growth rate of 18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 5.14B | -37.82% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | -0.00% |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.56B |
| Johnson & Johnson | 371.86B |
| UnitedHealth Group | 342.79B |
| AbbVie | 337.15B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.35B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |